The CERV-196 cell line was established from a poorly differentiated squamous cell carcinoma of the cervix; HPV-16 positive. In vitro established from the xenotransplant cervix carcinoma MRI-H-196 by Cell Lines Service. Primary xenotransplant was adopted to in vivo transplantation by Dr. Bodgen, Mason Research Institute.